ConvaTec Group PLC (CTEC)

Currency in GBP
241.40
+3.40(+1.43%)
Closed·
CTEC is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
239.00244.40
52 wk Range
209.40311.20
Key Statistics
Bid/Ask
210.00 / 250.00
Prev. Close
238
Open
240
Day's Range
239-244.4
52 wk Range
209.4-311.2
Volume
8.2M
Average Vol. (3m)
10.05M
1-Year Change
-6.7954%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CTEC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
303.67
Upside
+25.80%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

ConvaTec Group PLC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, bladder cancer, inflammatory bowel disease, and trauma. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, neurological disease, prostate enlargement or other causes. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for use in continuous infusion treatments for conditions such as Parkinson’s disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. Convatec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.

ConvaTec Group PLC Earnings Call Summary for H2/2025

  • ConvaTec achieved 6.4% organic revenue growth for 2025, marking fifth consecutive year of growth with operating margin expanding 110 bps to 22.3%
  • EPS increased 16% year-over-year; stock surged 10.84% to $59.66, delivering 80% gain over past year amid strong investor confidence
  • Infusion Care category led performance with 12.5% organic growth, driven by robust diabetes sector demand and expansion in other therapies
  • Company faces headwinds from InnovaMatrix sales decline and FDA warning letter on complaints management requiring operational attention
  • Management projects continued growth with new product launches planned for 2026-2027, focusing on high-return investments across chronic care portfolio
Last Updated: 02/24/2026, 06:54 AM
Read Full Transcript
ConvaTec Group investor slides for H2/2025
ConvaTec 2025 slides
Last Update: Feb 24, 2026
See full investor slides

Compare CTEC to Peers and Sector

Metrics to compare
CTEC
Peers
Sector
Relationship
P/E Ratio
36.1x23.6x−0.5x
PEG Ratio
−4.790.210.00
Price / Book
4.2x1.8x2.6x
Price / LTM Sales
2.6x2.0x3.2x
Upside (Analyst Target)
28.9%109.5%47.6%
Fair Value Upside
Unlock23.4%6.1%Unlock

Analyst Ratings

16 Buy
1 Hold
0 Sell
Ratings:
17 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 303.67
(+25.80% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Morgan Stanley
Buy2.80+15.99%2.70MaintainApr 14, 2026
Goldman Sachs
Buy3.10+28.42%3.60MaintainApr 08, 2026
Barclays
Buy3.22+33.39%3.25MaintainFeb 25, 2026
Berenberg
Buy3.40+40.85%3.30MaintainJan 23, 2026
RBC Capital
Buy3.15+30.49%-MaintainDec 18, 2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.09%
Dividend Yield
2.26%
Industry Median 2.56%
Annualized Payout
5.37
Paid unevenly
5-Years Growth
+4.91%
Growth Streak

Earnings

Latest Release
Feb 24, 2026
EPS / Forecast
0.10 / 0.10
Revenue / Forecast
1.26B / 1.25B
EPS Revisions
Last 90 days

CTEC Income Statement

People Also Watch

262.60
EMG
-0.08%
165.40
MONY
+0.27%
824.50
KNOS
+2.30%
192.00
SSPG
-0.05%
297.10
MNG
+0.58%

FAQ

What Is the ConvaTec Group (CTEC) Stock Price Today?

The ConvaTec Group stock price today is 241.40 GBP.

What Stock Exchange Does ConvaTec Group Trade On?

ConvaTec Group is listed and trades on the London Stock Exchange.

What Is the Stock Symbol for ConvaTec Group?

The stock symbol for ConvaTec Group is "CTEC."

Does ConvaTec Group Pay Dividends? What’s The Current Dividend Yield?

The ConvaTec Group dividend yield is 2.23%.

What Is the ConvaTec Group Market Cap?

As of today, ConvaTec Group market cap is 4.72B GBP.

What Is ConvaTec Group's Earnings Per Share (TTM)?

The ConvaTec Group EPS (TTM) is 0.09.

When Is the Next ConvaTec Group Earnings Date?

ConvaTec Group will release its next earnings report on Feb 24, 2026.

From a Technical Analysis Perspective, Is CTEC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has ConvaTec Group Stock Split?

ConvaTec Group has split 0 times.

How Many Employees Does ConvaTec Group Have?

ConvaTec Group has 10910 employees.

What is the current trading status of ConvaTec Group (CTEC)?

As of Apr 15, 2026, ConvaTec Group (CTEC) is trading at a price of 241.40 GBP, with a previous close of 238.00 GBP. The stock has fluctuated within a day range of 239.00 GBP to 244.40 GBP, while its 52-week range spans from 209.40 GBP to 311.20 GBP.

What Is ConvaTec Group (CTEC) Price Target According to Analysts?

The average 12-month price target for ConvaTec Group is 303.67 GBP, with a high estimate of 365.45829649 GBP and a low estimate of 252.43147657 GBP. 16 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +25.80% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.